DB

Debora Barton

Dr Barton has over 20 years of oncology experience, which includes 9 years of clinical management of oncology patients and enrolling patients in clinical trials in academia. In the pharmaceutical industry, she has experience in medical affairs and clinical development in both large pharmaceutical and small biotech companies, including regulatory interactions in the USA, Europe, Australia, and several countries around the world. She has undertaken an oncology product submission and subsequent marketing authorisation in the US and Europe and has built innovative clinical development plans coupled with clinical/safety teams' infrastructure in small biotech.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALA
ALA
12/11/251,276,490263,1573,372,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALA
ALA
12/11/25
Buy
1,013,333$0.096$97,279Exercise of options
ALA
ALA
12/11/25
Expiry
1,386,667$0.096$133,120Options expired
ALA
ALA
12/11/25
Exercise
1,013,333$0.052$52,693Exercise of options
ALA
ALA
26/11/24
Issued
354,000$0.185$65,490Director remuneration
ALA
ALA
04/12/23
Issued
618,000$0.088$54,384Director remuneration